Bacterial lysate for preventing breathing infections in preterm infants
Part of Infections, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study tests a medicine called a bacterial lysate, which might help prevent respiratory infections and wheezing in babies born early. It could reduce sickness and breathing problems in the first year of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby was born between 30 and 36 weeks of pregnancy.
- Your baby is now at least 6 weeks old and at least 37 weeks since your last period.
- Your baby does not have severe lung disease, heart problems, immune deficiency, or other serious conditions.
- You did not take immune-suppressing medications during pregnancy or while breastfeeding.
- Both parents or caregivers can read and speak Dutch or English and agree to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
This trial tests whether a medication can prevent wheezing after a baby's first chest infection, especially for those with risk factors. It may help reduce future breathing problems.
This study looks at the natural bacteria and germs in a premature baby's airways to see if they can help predict whether the baby will develop a lung problem called bronchopulmonary dysplasia (BPD). The goal is to find early clues that help doctors take better care of these babies.
This trial studies whether an early steroid treatment can lower the chance that children will go on to develop asthma after their first severe “wheezing” episode caused by a rhinovirus (a common cold virus). If you qualify, the goal is to prevent future asthma rather than just treat the current episode.
This study looks at whether giving babies a shot called nirsevimab (which helps protect against RSV, a common virus that can cause breathing problems) early in life can reduce wheezing later on. It compares babies who got the shot with those who didn't.
This study tests an experimental treatment to help premature babies' lungs grow stronger and reduce the need for a breathing machine. It might help your baby if they are very premature and still need extra oxygen and breathing support.
Hear when a new Wheezing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.